238 related articles for article (PubMed ID: 1383154)
1. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.
Watson DC; Robbins JB; Szu SC
Infect Immun; 1992 Nov; 60(11):4679-86. PubMed ID: 1383154
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model.
Jazani NH; Worobec E; Shahabi S; Nejad GB
Can J Microbiol; 2005 Apr; 51(4):319-24. PubMed ID: 15980894
[TBL] [Abstract][Full Text] [Related]
3. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.
Svenson SB; Lindberg AA
Infect Immun; 1981 May; 32(2):490-6. PubMed ID: 6166555
[TBL] [Abstract][Full Text] [Related]
4. Salmonella typhi O-polysaccharide--tetanus toxoid conjugated vaccine.
Saxena M; Di Fabio JL
Vaccine; 1994 Aug; 12(10):879-84. PubMed ID: 7526567
[TBL] [Abstract][Full Text] [Related]
5. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.
Svenson SB; Nurminen M; Lindberg AA
Infect Immun; 1979 Sep; 25(3):863-72. PubMed ID: 387597
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.
Robbins JB; Chu C; Schneerson R
Clin Infect Dis; 1992 Aug; 15(2):346-61. PubMed ID: 1381621
[TBL] [Abstract][Full Text] [Related]
7. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis.
Jörbeck HJ; Svenson SB; Lindberg AA
Infect Immun; 1981 May; 32(2):497-502. PubMed ID: 7019072
[TBL] [Abstract][Full Text] [Related]
8. Protection against mouse typhoid by artificial Salmonella vaccines.
Svenson SB; Lindberg AA
Scand J Infect Dis Suppl; 1980; Suppl 24():210-5. PubMed ID: 6163199
[TBL] [Abstract][Full Text] [Related]
9. Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain.
Lindberg AA; Segall T; Weintraub A; Stocker BA
Infect Immun; 1993 Apr; 61(4):1211-21. PubMed ID: 7681041
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
11. Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.
Simon R; Wang JY; Boyd MA; Tulapurkar ME; Ramachandran G; Tennant SM; Pasetti M; Galen JE; Levine MM
PLoS One; 2013; 8(5):e64680. PubMed ID: 23741368
[TBL] [Abstract][Full Text] [Related]
12. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
[TBL] [Abstract][Full Text] [Related]
13. Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines.
Lindberg AA; Robertsson JA
Infect Immun; 1983 Aug; 41(2):751-7. PubMed ID: 6347896
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy against
Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R
Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578
[TBL] [Abstract][Full Text] [Related]
15. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF
mBio; 2018 Mar; 9(2):. PubMed ID: 29511082
[TBL] [Abstract][Full Text] [Related]
16. Two Novel
Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
[TBL] [Abstract][Full Text] [Related]
17. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
[TBL] [Abstract][Full Text] [Related]
18. [The characteristics of the O-specific humoral immune response of mice vaccinated with Salmonella choleraesuis antigens].
Vaneeva NP; Alekseeva NIu; Torsunova GN; Bogdanova NB; Iastrebova NE; Elkina SI
Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):56-9. PubMed ID: 1711262
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
[TBL] [Abstract][Full Text] [Related]
20. Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.
Lu CH; Lee CJ; Kind P
Infect Immun; 1994 Jul; 62(7):2754-60. PubMed ID: 8005665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
